Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier
WebMD

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine
WebMD

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion
    WebMD

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community
    WebMD

    Community

    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Migraines & Headaches Health Center

Font Size
A
A
A

FDA OKs New Migraine Drug Treximet

Treximet Combines the Migraine Drug Imitrex With a Pain Reliever
By
WebMD Health News
Reviewed by Louise Chang, MD

April 16, 2008 -- The FDA has approved a new migraine drug called Treximet for the acute treatment of migraine attacks, with or without aura, in adults.

Treximet is a combination of sumatriptan (the active ingredient in the migraine drug Imitrex) and the anti-inflammatory painkiller naproxen sodium (the active ingredient in Aleve and Naprosyn).

Treximet is expected to be available in U.S. pharmacies by mid-May, according to a joint news release from GlaxoSmithKline and Pozen, the drug companies marketing Treximet.

GlaxoSmithKline and Pozen say that in clinical trials, Treximet worked better than a placebo or either of its two active ingredients alone, with relief lasting from two to 24 hours. Treximet also trumped a placebo at reducing symptoms associated with migraines, such as nausea and sensitivity to light and sound.

In clinical trials, Treximet was generally well tolerated, according to the drug companies; the most common adverse events reported within 24 hours of taking Treximet were dizziness; nausea; sleepiness; chest discomfort; pain in the neck, throat, and jaw; tightness and pressure; numbness or tingling; and dry mouth.

WebMD reported on the drug last year, before its name change from Trexima to Treximet.

GlaxoSmithKline and Pozen note that Treximet may cause an increased risk of serious cardiovascular clotting events, such as heart attack and stroke, and shouldn't be given to patients with heart disease.

And because naproxen sodium is a nonsteroidal anti-inflammatory drug, Treximet carries a risk of serious gastrointestinal problems, including bleeding and ulcers.

Today on WebMD

Business woman with hand on face and eyes closed
What aura looks like, triggers, and more.
woman with migraine
Get the truth about migraines.
 
headache in the bedroom
Keep headaches from ruining your sex life.
woman with hands on head
Test your knowledge of triggers, types, and more.
 
woman with migraine
Quiz
drinking coffee
Article
 
Migraines Headaches Basics
Article
acupuncture needles in woman's back
Slideshow
 
Tired young man
Slideshow
spraying perfume
Article
 
man with a headache
Article
headache in the bedroom
Article